In mice with STZ-induced diabetes, fasting blood glucose levels were significantly decreased after 4 weeks of treatment with JQ-R (Figure 1A), whereas the phosphorylation level of FGFR1 and that of its intracellular substrate FRS2, as well as the protein levels of GLUT-1, were markedly increased. The gene discussed is SLC2A1; the disease is diabetes mellitus.